Impact of Constipation Therapies on Severity of Gastroparesis and Constipation Symptoms in Relation to Gastric and Colonic Transit
- 3 March 2025
- journal article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (6) , e70013
Abstract
Introduction: Studies demonstrate an overlap of constipation with gastroparesis and functional dyspepsia, but the impact of treatments that target constipation on improving upper gastrointestinal (UGI) symptoms is unexplored. We quantified the effects of constipation medication therapies on UGI and constipation symptom severity in subjects presenting with symptoms of gastroparesis.Methods: Fifty‐six subjects with symptoms of gastroparesis underwent concurrent wireless motility capsule and gastric emptying scintigraphy and were recommended to receive either a new medication therapy for constipation or a change in constipation therapy based on investigator interpretation of test results. Gastroparesis Cardinal Symptom Index (GCSI), upper abdominal pain, and constipation scores were compared between baseline and 6 months. Data were compared between delayed or non‐delayed gastric emptying and the presence or absence of slow colonic transit.Key Results: Subjects with slow colonic transit had improvements in GCSI (p = 0.007) and constipation scores (p = 0.004) after treatment with a new or changed constipation medication, with the delayed emptying subgroup driving GCSI improvements (p = 0.004). Reductions in nausea/vomiting (p = 0.02) and early satiety/fullness subscores (p = 0.002) with trends to improved bloating/distention subscores (p = 0.06) were observed in this subgroup, but upper abdominal pain was unchanged. Subjects with normal colonic transit showed no improvement in GCSI scores regardless of gastric emptying status (p > 0.05).Conclusions and Inferences: Identifying and treating delayed colonic transit in gastroparetic (delayed gastric emptying) subjects improves global UGI symptoms as well as selected individual symptoms. Evaluation of whole gut motility as well as recognizing and managing extragastric delay may promote improved outcomes in these patients.Trial Registration: ClinicalTrials.gov: NCT02022826Keywords
Funding Information
- Medtronic
This publication has 30 references indexed in Scilit:
- Benefits of Prokinetics, Gastroparesis Diet, or Neuromodulators Alone or in Combination for Symptoms of GastroparesisClinical Gastroenterology and Hepatology, 2023
- Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal TransitClinical Gastroenterology and Hepatology, 2020
- Targeting Treatment of GastroparesisGastroenterology Clinics of North America, 2020
- Validation of Diagnostic and Performance Characteristics of the Wireless Motility Capsule in Patients With Suspected GastroparesisClinical Gastroenterology and Hepatology, 2019
- Investigation of Colonic and Whole-Gut Transit With Wireless Motility Capsule and Radiopaque Markers in ConstipationClinical Gastroenterology and Hepatology, 2009
- Dyspeptic Symptoms in Children: The Result of a Constipation-Induced Cologastric Brake?Clinical Gastroenterology and Hepatology, 2008
- Randomized Controlled Trial of Biofeedback, Sham Feedback, and Standard Therapy for Dyssynergic DefecationClinical Gastroenterology and Hepatology, 2007
- Does Neostigmine Increase Gastric Emptying in the Critically Ill? - Results of a Pilot StudyCritical Care and Resuscitation, 2003
- Voluntary suppression of defecation delays gastric emptyingDigestive Diseases and Sciences, 1993
- Effect of painless rectal distension on gastrointestinal transit of solid mealDigestive Diseases and Sciences, 1984